Annual ROE
601.92%
+821.53%+374.09%
December 1, 2023
Summary
- As of February 10, 2025, NRSN annual return on equity is 601.92%, with the most recent change of +821.53% (+374.09%) on December 1, 2023.
- During the last 3 years, NRSN annual ROE has risen by +1031.06% (+240.26%).
- NRSN annual ROE is now at all-time high.
Performance
NRSN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
381.51%
-26.11%-6.41%
September 1, 2024
Summary
- As of February 10, 2025, NRSN quarterly return on equity is 381.51%, with the most recent change of -26.11% (-6.41%) on September 1, 2024.
- Over the past year, NRSN quarterly ROE has dropped by -137.34% (-26.47%).
- NRSN quarterly ROE is now -93.86% below its all-time high of 6214.88%, reached on December 1, 2023.
Performance
NRSN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
NRSN ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +374.1% | -26.5% |
| 3 y3 years | +240.3% | +647.8% |
| 5 y5 years | +552.2% | +218.4% |
NRSN ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +374.1% | -93.9% | +164.1% |
| 5 y | 5-year | at high | +240.3% | -93.9% | +164.1% |
| alltime | all time | at high | +240.3% | -93.9% | +164.1% |
NeuroSense Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 381.51%(-6.4%) |
| Jun 2024 | - | 407.62%(-21.4%) |
| Mar 2024 | - | 518.85%(-91.7%) |
| Dec 2023 | 601.92%(-374.1%) | 6214.88%(-1144.1%) |
| Sep 2023 | - | -595.24%(+73.3%) |
| Jun 2023 | - | -343.41%(+79.2%) |
| Mar 2023 | - | -191.66%(+37.5%) |
| Dec 2022 | -219.61% | -139.41%(+45.5%) |
| Sep 2022 | - | -95.80%(+37.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | -69.65%(+10.5%) |
| Mar 2022 | - | -63.02%(-22.5%) |
| Dec 2021 | -44.87%(-89.5%) | - |
| Dec 2021 | - | -81.28%(-83.5%) |
| Sep 2021 | - | -493.73%(+29.1%) |
| Jun 2021 | - | -382.46%(+18.7%) |
| Mar 2021 | - | -322.31% |
| Dec 2020 | -429.14%(+222.4%) | - |
| Dec 2019 | -133.12% | - |
FAQ
- What is NeuroSense Therapeutics annual return on equity?
- What is the all time high annual ROE for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics annual ROE year-on-year change?
- What is NeuroSense Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics quarterly ROE year-on-year change?
What is NeuroSense Therapeutics annual return on equity?
The current annual ROE of NRSN is 601.92%
What is the all time high annual ROE for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high annual return on equity is 601.92%
What is NeuroSense Therapeutics annual ROE year-on-year change?
Over the past year, NRSN annual return on equity has changed by +821.53% (+374.09%)
What is NeuroSense Therapeutics quarterly return on equity?
The current quarterly ROE of NRSN is 381.51%
What is the all time high quarterly ROE for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high quarterly return on equity is 6214.88%
What is NeuroSense Therapeutics quarterly ROE year-on-year change?
Over the past year, NRSN quarterly return on equity has changed by -137.34% (-26.47%)